Amgen's BiTE® Immunotherapy Blinatumomab Receives FDA Priority Review Designation In Acute Lymphoblastic Leukemia
Additional Global Regulatory Filings Reinforce Commitment to Addressing Significant Unmet Needs for Patients With This Aggressive Cancer With Limited Treatment Options
Amgen Announces Positive Top-Line Results From Phase 3 Study Evaluating The Efficacy And Safety Of Biosimilar Candidate ABP 501 Compared With Adalimumab In Patients With Moderate-To-Severe Plaque Psoriasis
Primary Efficacy Analysis Demonstrates Clinical Equivalence
THOUSAND OAKS, Calif., Oct.
Hospira Issues a Voluntary Nationwide Recall of One Lot of Vancomycin Hydrochloride for Injection USP, Equivalent to 1 G Vancomycin (Sterile Powder) Due to Uncontrolled Storage During Transit
Ironwood and Actavis to Present Linaclotide Data at the American College of Gastroenterology 2014 Annual Scientific Meeting
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
Teva Announces Initiation of New Drug Application and Positive Results from Second Human Abuse Liability Study for CEP-33237 (Hydrocodone Bitartrate) Extended-Release Tablets
EYLEA® (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO)
Health Care Providers and Services Stocks under Review - Community Health Systems, Tenet Healthcare, UnitedHealth, Molina Healthcare, and Cigna
Editor Note: For more information about this release, please scroll to bottom.
LONDON, October 6, 2014
Johnson & Johnson Vision Care Companies Announces Sight For Kids Screens 20 Million Children, Expands To Kenya and Turkey
Milestones Honor World Sight Day
JACKSONVILLE, Fla., Oct.